Stonepine Capital Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History
Bought
Maintained
Sold
Other funds holding BDSI
DM
NCM
RCMNY
SFM
EA
ACA
EMFAT
Stonepine Capital Management's BDSI Position: Q2 2020 in Review
Stonepine Capital Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q2 2020, closing a stake of 755,000 shares — an estimated $2.86M sold.
Stonepine Capital Management first reported a position in BDSI in Q1 2016 and held it in 14 quarters. The position peaked at $14.7M in Q4 2018. 158 funds tracked by Wall St. Rank hold BDSI as of Q2 2020.
- Stonepine Capital Management reported no remaining BioDelivery Sciences International, Inc. position as of Q2 2020 after selling out during the quarter.
- Stonepine Capital Management sold 755,000 BioDelivery Sciences International, Inc. shares in Q2 2020, an estimated $2.86M.
- Stonepine Capital Management first reported a position in BioDelivery Sciences International, Inc. in Q1 2016 and held it in 14 quarters.
- Stonepine Capital Management's BioDelivery Sciences International, Inc. position peaked at $14.7M in Q4 2018.
- 158 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q2 2020.
Based on Stonepine Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.